Synthesis (and alternative proof of configuration) of the scyphostatin C(1′)-C(20′) trienoyl fragment

Organic Letters

Volumn 2, Issue 10, 2000, Pages 1481-1483

  Hoye, Thomas R ^a   Tennakoon, Manomi A ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ENZYME INHIBITOR; PYRONE DERIVATIVE; SCYPHOSTATIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

AMIDES; ENZYME INHIBITORS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PYRONES; STEREOISOMERISM;

EID: 0034682135     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0058386     Document Type: Article

References (32)

1. Tanaka, M.; Nara, F.; Suzuki-Konagai, K.; Hosoya, T.; Ogita, T. J. Am. Chem. Soc. 1997, 119, 7871-2.
2. (a) Nara, F.; Tanaka, M.; Hosoya, T.; Suzuki-Konagai, K.; Ogita, T. J. Antibiot. 1999, 52, 525-30.
3. (b) Nara, F.; Tanaka, M.; Masuda-Inoue, S.; Yamasato, Y.; Doi-Yoshioka, H.; Suzuki-Konagai, K.; Kumakura, S.; Ogita, T. J. Antibiot. 1999, 52, 531-5.
4. (a) Tanaka, M.; Nara, F.; Yamasato, Y.; Masuda-Inoue, S.; DoiYoshioka, H.; Kumakura, S.; Enokita, R.; Ogita, T. J. Antibiot. 1999, 52, 670-3.
5. (b) Tanaka, M.; Nara, F.; Yamasato, Y.; Ono, Y.; Ogita, T. J. Antibiot. 1999, 52, 827-30.
6. Saito, S.; Tanaka, N.; Fujimoto, K.; Kogen, H. Org. Lett. 2000, 2, 505-6.
7. For example, see: (a) Cha, J. K.; Christ, W. J.; Finan, J. M.; Fujioka, H.; Kishi, Y.; Klein, L. L.; Ko, S. S.; Leder, J.; McWhorter, W. W., Jr.; Pfaff, K.-P.; Yonaga, M.; Uemura, D.; Hirata, Y. J. Am Chem. Soc. 1982, 104, 7369-7371 and preceding papers.
8. (b) Hoye, T. R.; Suhadolnik, J. C. J. Am. Chem. Soc. 1987, 109, 4402-4403.
9. (c) Gale, J. B.; Yu, J.-G.; Khare, A.; Hu, X. E.; Ho, D. H.; Cassady, J. M. Tetrahedron Lett. 1993, 34, 5851-4.
10. (d) Oikawa, H.; Matsud, I.; Ichihara, A.; Kohmoto, K. Tetrahedron Lett. 1994, 35, 1223-6.
11. (e) Boyle, C. D.; Harmange, J.-C.; Kishi, Y. J. Am. Chem. Soc. 1994, 116, 4995-6.
12. (f) Harmange, J.-C.; Boyle, C. D.; Kishi, Y. Tetrahedron Lett. 1994, 35, 6819-22.
13. (g) Kishi, Y.; Boyle, C. D. Tetrahedron Lett. 1995, 36, 5695-8.
14. (h) Kishi, Y.; Boyle, C. D. Tetrahedron Lett. 1995, 36, 4579-82.
15. (i) Zheng, W.; DeMattei, J. A.; Wu, J. P.; Duan, J. J. W.; Cook, L. R.; Oinuma, H.; Kishi, Y. J. Am Chem. Soc. 1996, 118, 7946-68.
16. (j) Sasaki, M.; Matsumori, N.; Maruyama, T.; Nonomura, T.; Murata, M.; Tachibana, K.; Yasumoto T. Angew. Chem., Int. Ed. Engl. 1996, 35, 1672-5.
17. (k) Nonomura, T.; Sasaki, M.; Matsumori, N.; Murata, M.; Tachibana, K.; Yasumoto T. Angew. Chem., Int. Ed. Engl. 1996, 35, 1675-8.
18. (l) Kishi, Y. Pure Appl. Chem. 1998, 70, 339-344.
19. (m) Kobayashi, Y.; Lee, J.; Tezuka, K.; Kishi, Y. Org. Lett. 1999, 1, 2177-80.
20. (n) Lee, J.; Kobayashi, Y.; Tezuka, K.; Kishi, Y. Org. Lett. 1999, 1, 2181-4.
21. Lin, G.; Xu, W. Tetrahedron 1996, 52, 5907-12.
22. 4 reduction of meso-α,α′-dimethyl glutaric anhydride, which in turn was prepared by the method described by Wiley: P. F.; Gerzon, K.; Flynn, E. H.; Sigal, M. V.; Weaver, O.; Quarck, U. C.; Chauvette. R. R.; Monahan, R. J. Am. Chem. Soc. 1957, 79, 6062-70.
23. Lautens, M.; Tam, W.; Lautens, J.; Edwards, L.;. Crudden, C.; Smith, C. J. Am. Chem. Soc. 1995, 117, 6863-79.
24. Hoye, R. C.; Baigorria, A.; Danielson, M.; Pragman, A.; Rajapakse, H. J. Org. Chem. 1999, 64, 2450-3.
25. (a) Okukado, N.; Negishi, E.-I. Tetrahedron Lett. 1978, 19, 2357-60.
26. (b) Negishi, E.-I. Pure. Appl. Chem. 1981, 53, 2333-56.
27. Guanti, G.; Banfi, L.; Narisano, E.; Zannetti, M. T. J. Org. Chem. 1993, 58, 1508-14.
28. (a) Kinoshita, M.; Takami, H.; Taniguchi, M.; Tamai, T. Bull. Chem. Soc. Jpn. 1987, 60, 2151-61.
29. (b) Bérubé, G.; Deslongchamps, P. Can. J. Chem. 1990, 68, 404-11.
30. 2 separable) E,E,Z-isomer.
31. Basha, A.; Lipton, M.; Weinreb, S. M. Tetrahedron Lett. 1977, 48, 4171-4.
32. 1 and the values we read from the provided spectra, we have used the latter set for the analyses summarized in Figure 1. The values that we recorded from the provided proton and carbon spectra of scyphostatin can be found in Table C in the Supporting Information.